Literature DB >> 6809024

Effect of pirprofen on glibenclamide kinetics and response.

P J Morrison, H J Rogers, R G Spector, I D Bradbrook, V A John.   

Abstract

Pirprofen (a new non-steroidal anti-inflammatory agent), 200 mg 8 hourly, or placebo was administered orally to eight normal volunteers to investigate its effect on the pharmacokinetics and glucose and insulin responses after 1 mg i.v. glibenclamide. No significant changes were produced in these measures and in vitro studies showed no displacement of glibenclamide by pirprofen from plasma protein binding.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6809024      PMCID： PMC1427576          DOI： 10.1111/j.1365-2125.1982.tb04949.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  13 in total

1.  Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen.

Authors:  P Trinder
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

2.  Sounding board. Prostaglandins, the glucoreceptor, and diabetes.

Authors:  R P Robertson; S A Metz
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

3.  Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.

Authors:  K F Brown; M J Crooks
Journal:  Biochem Pharmacol       Date:  1976-05-15       Impact factor: 5.858

4.  ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.

Authors:  R D Brown; J E Manno
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

5.  Noncompartmental determination of the steady-state volume of distribution.

Authors:  L Z Benet; R L Galeazzi
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

6.  [Studies on the bioavailability of glibenclamide].

Authors:  W Rupp; O Christ; W Fülberth
Journal:  Arzneimittelforschung       Date:  1972-02

7.  Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.

Authors:  S M Pond; D J Birkett; D N Wade
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

8.  Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects.

Authors:  P Micossi; A E Pontiroli; S H Baron; R C Tamayo; F Lengel; M Bevilacqua; U Raggi; G Norbiato; P P Foà
Journal:  Diabetes       Date:  1978-12       Impact factor: 9.461

9.  Comparison of the pharmacokinetics of glipizide and glibenclamide in man.

Authors:  L Balant; J Fabre; G R Zahnd
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

Review 10.  Drug interactions with oral sulphonylurea hypoglycaemic drugs.

Authors:  J M Hansen; L K Christensen
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546
View more
  5 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

2.  Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.

Authors:  D Hartmann; A Korn; M Komjati; G Heinz; P Haefelfinger; R Defoin; W K Waldhäusl
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 3.  Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; R Beresford
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

Review 4.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

5.  Lack of effect of tenoxicam on glibornuride kinetics and response.

Authors:  K Stoeckel; V Trueb; U C Dubach; R C Heintz; V Ascalone; I Forgo; U Hennes
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.